Technical Analysis for ONCS - OncoSec Medical Incorporated

Grade Last Price % Change Price Change
F 4.5 -6.83% -0.33
ONCS closed up 3.65 percent on Thursday, April 15, 2021, on 1.31 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ONCS trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish -6.83%
Pocket Pivot Bullish Swing Setup -6.83%
200 DMA Resistance Bearish -3.43%
Stochastic Reached Oversold Weakness -3.43%
Wide Bands Range Expansion -3.43%
Oversold Stochastic Weakness -3.43%
MACD Bearish Signal Line Cross Bearish -2.39%
Wide Bands Range Expansion -2.39%
Down 3 Days in a Row Weakness -2.39%
Fell Below 200 DMA Bearish -2.81%
Older End-of-Day Signals for ONCS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 25 minutes ago
Down 5% about 4 hours ago
1.5x Volume Pace about 4 hours ago
Down 3% about 4 hours ago
Down 2 % about 4 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OncoSec Medical Incorporated, a hybrid device and gene therapy biotechnology company, designs, develops, and commercializes medical approaches principally immunotherapy for the treatment of solid tumors in the United States. Its clinical programs include three Phase II clinical trials to assess the ImmunoPulse technology in patients with melanoma, Merkel cell carcinoma, and cutaneous T-cell lymphoma. It has a collaboration agreement with Heat Biologics, Inc. to evaluate the combination of immunotherapy platforms. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biology Solid Tumors Immunotherapy Lymphoma Cancer Treatments Gene Therapy Virotherapy Melanoma Carcinoma Genetic Engineering Cutaneous T Cell Lymphoma Heat Biologics

Is ONCS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.1598
52 Week Low 1.49
Average Volume 206,811
200-Day Moving Average 4.84
50-Day Moving Average 5.80
20-Day Moving Average 5.13
10-Day Moving Average 5.01
Average True Range 0.40
ADX 21.28
+DI 17.93
-DI 23.55
Chandelier Exit (Long, 3 ATRs ) 5.09
Chandelier Exit (Short, 3 ATRs ) 5.64
Upper Bollinger Band 5.86
Lower Bollinger Band 4.40
Percent B (%b) 0.29
BandWidth 28.41
MACD Line -0.26
MACD Signal Line -0.25
MACD Histogram -0.0096
Fundamentals Value
Market Cap 135.07 Million
Num Shares 28 Million
EPS -5.93
Price-to-Earnings (P/E) Ratio -0.81
Price-to-Sales 0.00
Price-to-Book 9.80
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.40
Resistance 3 (R3) 5.41 5.23 5.31
Resistance 2 (R2) 5.23 5.08 5.23 5.27
Resistance 1 (R1) 5.03 5.00 4.94 5.02 5.24
Pivot Point 4.85 4.85 4.81 4.85 4.85
Support 1 (S1) 4.65 4.70 4.56 4.64 4.42
Support 2 (S2) 4.47 4.62 4.47 4.39
Support 3 (S3) 4.27 4.47 4.36
Support 4 (S4) 4.26